Gofen & Glossberg’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.3M | Buy |
16,983
+29
| +0.2% | +$3.64K | 0.06% | 182 |
|
|
2022
Q3 | $1.86M | Sell |
16,954
-196
| -1% | -$24.9K | 0.05% | 192 |
|
|
2022
Q2 | $2.27M | Sell |
17,150
-200
| -1% | -$26.2K | 0.06% | 184 |
|
|
2022
Q1 | $2.3M | Sell |
17,350
-106
| -0.6% | -$12.7K | 0.05% | 189 |
|
|
2021
Q4 | $2.03M | Sell |
17,456
-1,394
| -7% | -$164K | 0.04% | 196 |
|
|
2021
Q3 | $2.26M | Buy |
18,850
+255
| +1% | +$29.7K | 0.05% | 186 |
|
|
2021
Q2 | $2.23M | Sell |
18,595
-1,125
| -6% | -$123K | 0.05% | 186 |
|
|
2021
Q1 | $1.96M | Hold |
19,720
| – | – | 0.05% | 187 |
|
|
2020
Q4 | $1.97M | Buy |
19,720
+260
| +1% | +$27.5K | 0.05% | 178 |
|
|
2020
Q3 | $2.13M | Sell |
19,460
-96
| -0.5% | -$10.7K | 0.07% | 158 |
|
|
2020
Q2 | $2.07M | Sell |
19,556
-79
| -0.4% | -$8.16K | 0.07% | 153 |
|
|
2020
Q1 | $1.75M | Sell |
19,635
-58
| -0.3% | -$5.46K | 0.07% | 157 |
|
|
2019
Q4 | $1.96M | Sell |
19,693
-50
| -0.3% | -$4.71K | 0.06% | 168 |
|
|
2019
Q3 | $1.76M | Sell |
19,743
-7
| -0% | -$607 | 0.06% | 173 |
|
|
2019
Q2 | $1.63M | Sell |
19,750
-302
| -2% | -$23.7K | 0.06% | 176 |
|
|
2019
Q1 | $1.62M | Sell |
20,052
-128
| -0.6% | -$10.1K | 0.06% | 169 |
|
|
2018
Q4 | $1.53M | Sell |
20,180
-50
| -0.2% | -$3.9K | 0.06% | 170 |
|
|
2018
Q3 | $1.6M | Sell |
20,230
-181
| -0.9% | -$13.7K | 0.06% | 181 |
|
|
2018
Q2 | $1.43M | Sell |
20,411
-4,200
| -17% | -$302K | 0.05% | 184 |
|
|
2018
Q1 | $1.72M | Sell |
24,611
-2,174
| -8% | -$151K | 0.06% | 177 |
|
|
2017
Q4 | $1.86M | Sell |
26,785
-1,500
| -5% | -$101K | 0.07% | 179 |
|
|
2017
Q3 | $1.92M | Sell |
28,285
-682
| -2% | -$43.1K | 0.07% | 173 |
|
|
2017
Q2 | $1.98M | Sell |
28,967
-3,133
| -10% | -$205K | 0.08% | 170 |
|
|
2017
Q1 | $2M | Sell |
32,100
-1,068
| -3% | -$62.2K | 0.08% | 165 |
|
|
2016
Q4 | $1.81M | Sell |
33,168
-13,305
| -29% | -$755K | 0.07% | 166 |
|
|
2016
Q3 | $3.05M | Sell |
46,473
-1,609
| -3% | -$105K | 0.13% | 128 |
|
|
2016
Q2 | $2.9M | Sell |
48,082
-36,768
| -43% | -$2.14M | 0.12% | 132 |
|
|
2016
Q1 | $4.78M | Buy |
84,850
+233
| +0.3% | +$14K | 0.2% | 103 |
|
|
2015
Q4 | $5.75M | Sell |
84,617
-980
| -1% | -$64.3K | 0.25% | 97 |
|
|
2015
Q3 | $5.45M | Sell |
85,597
-645
| -0.7% | -$42.4K | 0.25% | 99 |
|
|
2015
Q2 | $5.49M | Sell |
86,242
-150
| -0.2% | -$10.3K | 0.23% | 101 |
|
|
2015
Q1 | $5.91M | Buy |
86,392
+12,911
| +18% | +$897K | 0.25% | 95 |
|
|
2014
Q4 | $5.17M | Buy |
73,481
+1,278
| +2% | +$91.5K | 0.22% | 102 |
|
|
2014
Q3 | $5.16M | Buy |
72,203
+252
| +0.4% | +$18.4K | 0.23% | 100 |
|
|
2014
Q2 | $5.35M | Buy |
71,951
+31,254
| +77% | +$2.26M | 0.24% | 104 |
|
|
2014
Q1 | $2.76M | Buy |
40,697
+36,297
| +825% | +$2.34M | 0.13% | 132 |
|
|
2013
Q4 | $261K | Buy |
+4,400
| New | +$239K | 0.01% | 360 |
|
Other funds holding AZN
AWA
Gofen & Glossberg's AZN Position: Q4 2022 in Review
Gofen & Glossberg increased its AstraZeneca (AZN) stake by 0.17% in Q4 2022, buying an estimated $3.64K and bringing the position to 16,983 shares worth $2.3M. The position accounts for 0.06% of the portfolio, ranked #182.
Gofen & Glossberg first reported a position in AZN in Q4 2013 and has held it in 37 quarters since. The position peaked at $5.91M in Q1 2015. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.
- Gofen & Glossberg held 16,983 shares of AstraZeneca worth $2.3M as of Q4 2022.
- Gofen & Glossberg bought 29 AstraZeneca shares in Q4 2022, an estimated $3.64K.
- AstraZeneca made up 0.06% of Gofen & Glossberg's portfolio in Q4 2022, its #182 holding.
- Gofen & Glossberg first reported a position in AstraZeneca in Q4 2013 and has held it in 37 quarters since.
- Gofen & Glossberg's AstraZeneca position peaked at $5.91M in Q1 2015.
- 1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.